Type
Blood Testing
Biomarkers
11
Duration
2 hours
Results
7 days
Specialized cancer screening for women with tumor markers and imaging.
Cancer risk screening uses blood-based tumor markers, genetic risk panels, or non-invasive tests to assess your risk for various cancers. Blood-based markers like PSA, CA-125, CEA, and AFP can detect elevated levels associated with certain cancer types. These tests are not diagnostic on their own but identify individuals who may benefit from further investigation. Early detection dramatically improves outcomes for most cancers. Screening programs are especially valuable for those with family history, known genetic risk factors, or age-related risk increases.
Key Details
- Sample
- Blood draw (or stool for FIT)
- Fasting
- Usually not required
- Results
- 3–7 business days
Who Is This For?
People with family history of cancer wanting proactive screening. Those over 40 wanting regular cancer risk monitoring. Anyone seeking peace of mind through early detection. People with known genetic risk factors (e.g., BRCA carriers).
What's Included
Preparation Required
No special fasting required for most tumor marker blood tests. For FIT (stool-based) screening, follow the kit instructions carefully. Bring relevant family history information.
Panel Categories
Biomarkers Tested
11A biomarker associated with some breast cancers; used to monitor treatment response in patients with metastatic breast cancer.
A biomarker commonly used in the diagnosis and management of pancreatic and gastrointestinal cancers. Elevated levels can also be found in other conditions such as liver disease.
Tumor marker; elevated levels may indicate certain cancers, particularly gastrointestinal cancers.
The cortisol awakening response (CAR) is a period of increased cortisol secretory activity initiated by morning awakening and typically peaking between 30 and 45min post awakening
Measures only the unbound PSA in the blood.
Imbalances in gut pH influence short-chain fatty acid production and their effects.
- Category
- Diagnostic
- Sample Type
- Cancer screening
- Duration
- 2 hours
- Results
- 7 days